TandemLife is now a part of LivaNova, Learn More Here.

COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.

The Power to Recover.

If you’re looking for the ultimate in left ventricular unloading, our classic TandemHeart kit is the only choice.

Why TandemHeart?

Advanced hemodynamic support devices are designed to offer a high degree of circulatory support. Three percutaneous platforms are commercially available:

(1) percutaneous cardiopulmonary bypass (pCPB)

(2) intraluminal axial support (e.g., Impella)

(3) left atrium-to-femoral artery bypass (TandemHeart)

TandemHeart forged the temporary circulatory support device market with the launch of a one-of-a-kind Transseptal Cannula that offers a unique approach to circulatory support by balancing two critical factors: (1) a powerful pump for end organ perfusion and (2) transseptal cannulation of the left atrium to decompress and rest the left ventricle. Among all your available circulatory support options, only TandemHeart provides a steady supply of oxygenated blood to the organs while decompressing the left ventricle to reduce the work of the heart.

The TandemHeart kit components are indicated for temporary cardiopulmonary bypass up to 6 hours.

Features

Physiologic levels of pressure (90 mmHg) and
Full power support (0.8-0.9 Watts) for organ perfusion
Maximum left ventricular unloading, up to 80-90%
Decreased myocardial oxygen demand for potential

Request a Demo

Included Products

LifeSPARC Pump

LifeSPARC Pump

Experience bypass in the palm of your hand. The TandemHeart Pump can be used in the Cardiac Catherization Lab or the Operating Room in a vast variety of configurations.

ProtekSolo Transseptal Cannula

ProtekSolo Transseptal Cannula

The one and only percutaneous option for LA sourcing. The curved distal tip enables optimal placement in the left atrium and features 14 side holes for exceptional drainage.

ProtekSolo Arterial

ProtekSolo Arterial

Safety Enhanced. The Protek Arterial line of cannulae includes two must-have features. A stop ring to prevent over insertion and suture wings for secure attachment ot the patient.

Left Atrial Cannulation

Left Atrial Cannulation

The only device that percutaneously bypasses the Left Ventricle enabling increased Cardiac Power Output. TandemHeart does the majority of the work for the heart while allowing the LV to rest.

Power to Recover

TandemHeart provides a steady supply of oxygenated blood to the organs while decompressing the left ventricle to reduce the work of the heart.

90 mmHg pressure throughout the entire cardiac cycle
Up to 5 LPM of blood flow
Produces .8-.9 Watts of Cardiac Power
Up to 90% unloading

Other cannulation methods fail to provide the same level of support.